{
    "name": "cosyntropin",
    "comment": "Rx",
    "other_names": [
        "Cortrosyn",
        "Synthetic ACTH"
    ],
    "classes": [
        "Diagnostics",
        "Endocrine"
    ],
    "source": "https://reference.medscape.com/drug/cortrosyn-synthetic-acth-cosyntropin-342817",
    "pregnancy": {
        "common": [
            "Safety in pregnant women not established; there are no adequate and well controlled studies of cosyntropin in pregnant women; therapy should be used during pregnancy only if potential benefit justifies potential risk to fetus"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not known whether cosyntropin is excreted into human milk; because many drugs are excreted in human milk and because of potential for serious adverse reactions in nursing infants from cosyntropin, caution should be exercised when treatment is administered to a nursing woman"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to cosyntropin, synthetic ACTH, or to any excipients"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Use caution in patients with gastrointestinal disease, cardiovascular disease, hepatic disease, infections, myasthenia gravis, ocular disease, psychiatric disturbances, osteoporosis, renal disease, thyroid disease",
                "Reactions including anaphylaxis are possible; monitor patients for hypersensitivity reactions and treat as needed"
            ],
            "specific": [
                {
                    "type": "Diagnostic inaccuracies ",
                    "description": [
                        "Accuracy of diagnosis can be complicated by concomitant medications taken by patient; any condition that elevates or lowers cortisol binding globulin levels may increase or decrease plasma total cortisol levels, respectively; for example, cortisol binding globulin levels can be low in cirrhosis or nephrotic syndrome",
                        "Cortisone or hydrocortisone use might falsely elevate or, in a paradoxical response, lower plasma cortisol levels; spironolactone use may result in falsely elevated cortisol levels; patients receiving cortisone, hydrocortisone or spironolactone should omit their pre-test doses on the day selected for testing",
                        "Use of synthetic glucocorticoid preparations (oral, inhaled, or injectable) might suppress plasma cortisol levels",
                        "Use of estrogen-containing drugs increases cortisol binding globulin levels which can elevate plasma total cortisol levels; to ensure accuracy of plasma total cortisol levels, discontinue estrogen-containing drugs 4-6 weeks prior to testing to allow cortisol binding globulin levels to return to levels within reference range; alternatively, concomitant measurement of cortisol binding globulin at time of testing can be done; if cortisol binding globulin levels are elevated, plasma total cortisol levels are considered inaccurate"
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Minor",
            "interaction_with": "amphotericin B deoxycholate",
            "description": {
                "common": "amphotericin B deoxycholate, cosyntropin. Mechanism: unspecified interaction mechanism. Minor/Significance Unknown. Potential for hypokalemia."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "bendroflumethiazide",
            "description": {
                "common": "cosyntropin, bendroflumethiazide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "bumetanide",
            "description": {
                "common": "cosyntropin, bumetanide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "chlorothiazide",
            "description": {
                "common": "cosyntropin, chlorothiazide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "chlorthalidone",
            "description": {
                "common": "cosyntropin, chlorthalidone. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "cyclopenthiazide",
            "description": {
                "common": "cosyntropin, cyclopenthiazide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "ethacrynic acid",
            "description": {
                "common": "cosyntropin, ethacrynic acid. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "furosemide",
            "description": {
                "common": "cosyntropin, furosemide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "hydrochlorothiazide",
            "description": {
                "common": "cosyntropin, hydrochlorothiazide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "indapamide",
            "description": {
                "common": "cosyntropin, indapamide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "methyclothiazide",
            "description": {
                "common": "cosyntropin, methyclothiazide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "metolazone",
            "description": {
                "common": "cosyntropin, metolazone. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "torsemide",
            "description": {
                "common": "cosyntropin, torsemide. pharmacodynamic synergism. Minor/Significance Unknown. Possible enhanced electrolyte loss."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Flushing",
            "percent": null
        },
        {
            "name": "Mild fever",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Chronic pancreatitis",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Peripheral edema",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "Bradycardia",
            "percent": null
        },
        {
            "name": "Adrenal hemorrhage",
            "percent": null
        },
        {
            "name": "Anaphylactic reaction",
            "percent": null
        }
    ]
}